Your browser doesn't support javascript.
Rare Diseases: Needs and Impact for Patients and Families: A Cross-Sectional Study in the Valencian Region, Spain.
Gimenez-Lozano, Cristina; Páramo-Rodríguez, Lucía; Cavero-Carbonell, Clara; Corpas-Burgos, Francisca; López-Maside, Aurora; Guardiola-Vilarroig, Sandra; Zurriaga, Oscar.
  • Gimenez-Lozano C; Preventive Medicine and Public Health, Hospital Universitario Doctor Peset, 46017 Valencia, Spain.
  • Páramo-Rodríguez L; Rare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, 46020 Valencia, Spain.
  • Cavero-Carbonell C; Rare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, 46020 Valencia, Spain.
  • Corpas-Burgos F; Economic, Demographic and Social Statistics Service, Valencian Institute of Statistics, Valencian Region, 46020 Valencia, Spain.
  • López-Maside A; Directorate General for Public Health and Addictions, Regional Ministry of Health, Valencian Region, 46020 Valencia, Spain.
  • Guardiola-Vilarroig S; Directorate General for Public Health and Addictions, Regional Ministry of Health, Valencian Region, 46020 Valencia, Spain.
  • Zurriaga O; Rare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, 46020 Valencia, Spain.
Int J Environ Res Public Health ; 19(16)2022 08 19.
Article in English | MEDLINE | ID: covidwho-2023672
ABSTRACT
Families with rare diseases (RDs) have unmet needs that are often overlooked by health professionals. Describing these needs and the impact of the disease could improve their medical care. A total of 163 surveys were obtained from patients visiting primary care centres in the Valencian Region (Spain), during 2015-2017, with a confirmed or suspected diagnosis of RD. Of the 84.7% with a confirmed diagnosis, 50.4% had a diagnostic delay exceeding one year, and it was more prevalent among adults (62.2%). Families with paediatric patients were in a worse economic situation, with lower incomes and higher monthly disease-related expenses (€300 on average). These expenses were incurred by 66.5% of families and were mainly for medication (40.3%). Among them, 58.5% reported not being able to afford adjuvant therapies. The disease had an impact on 73.1% of families, especially on their routine and emotional state. Expenses, needs, and impacts were more frequent among families of patients with a history of hospitalisation or deterioration. Patients with delayed diagnosis had a higher consumption of drugs prior to diagnosis. People affected by RDs in the Valencian Region need therapies to improve their autonomy and emotional state. Health professionals should be aware of these needs.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Rare Diseases / Delayed Diagnosis Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Child / Humans Country/Region as subject: Europa Language: English Year: 2022 Document Type: Article Affiliation country: Ijerph191610366

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Rare Diseases / Delayed Diagnosis Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Child / Humans Country/Region as subject: Europa Language: English Year: 2022 Document Type: Article Affiliation country: Ijerph191610366